Corcept Therapeutics · 3 hours ago
Regional Business Director, Oncology - Chicago Region
United States
Full-time
Remote
Director/Executive
$235K/yr - $274K/yr
10+ years exp
Maximize your interview chancesBiotechnologyMedical
No H1B
Insider Connection @Corcept Therapeutics
Get 3x more responses when you reach out via email instead of LinkedIn.
Responsibilities
Cultivate a ‘high trust’ culture that inspires excellence, puts people first, and works together to bring out the best in individuals with an unwavering commitment to patients
Collaborate with cross-functional leaders and teams to develop comprehensive brand and sales strategies. Lead the execution of these strategies to drive revenue growth and market share within their Region
Work with Vice President, Oncology, Human Resources and Talent Acquisition to lead the recruitment, development, and retention of top-tier talent
Execute the launch plans to ensure a successful market introduction and rapid adoption of new products
Establish sales goals and monitor performance against targets
Identify and prioritize key accounts, including oncologists, hospitals, and cancer treatment centers
Build and maintain strong relationships with key opinion leaders (KOLs), healthcare professionals, and other stakeholders in the GYN/ONC therapeutic area
Conduct market analysis to understand regional trends, competitive landscape, and customer needs
Collaborate with marketing, medical affairs, and other cross-functional teams to align strategies and ensure consistent messaging
Qualification
Find out how your skills align with this job's requirements. If anything seems off, you can easily click on the tags to select or unselect skills to reflect your actual expertise.
Required
Demonstrated ability to build a sales team aligned with a high-performance & patient-centric culture.
Strong leader with a proven track record of launching teams and products into the Oncology market.
Ability to cultivate a ‘high trust’ culture that inspires excellence and puts people first.
Experience collaborating with cross-functional leaders and teams to develop comprehensive brand and sales strategies.
Experience executing launch plans to ensure a successful market introduction and rapid adoption of new products.
Ability to establish sales goals and monitor performance against targets.
Experience identifying and prioritizing key accounts, including oncologists, hospitals, and cancer treatment centers.
Ability to build and maintain strong relationships with key opinion leaders (KOLs), healthcare professionals, and other stakeholders in the GYN/ONC therapeutic area.
Experience conducting market analysis to understand regional trends, competitive landscape, and customer needs.
Experience collaborating with marketing, medical affairs, and other cross-functional teams to align strategies and ensure consistent messaging.
Bachelor’s degree plus 10+ years of commercial experience in pharmaceuticals.
Extensive understanding and experience in both clinical aspects and the business of oncology, with a focus on gyne/onc.
In-depth knowledge of U.S. payer and market access dynamics.
Applicants must be currently authorized to work in the United States on a full-time basis.
Preferred
Proven experience in successfully launching key products/brands in the oncology field.
Track record in launching and managing sales of oncology products, particularly in the GYN/ONC therapeutic area.
Previous success building and leading high-performing teams.
Inspirational leadership style with the ability to motivate and encourage accountability.
Strategic thinker with strong business acumen and the ability to translate strategy into actionable sales plans.
Company
Corcept Therapeutics
Corcept Therapeutics discovers and develops drugs that regulate the effects of cortisol.
201-500 employees
Funding
Current Stage
Public CompanyTotal Funding
$119.09MKey Investors
Paperboy Ventures
2012-07-02IPO· undefined
2012-04-10Post Ipo Equity· $0.53M
2011-01-21Post Ipo Equity· $39M
Leadership Team
Roberto Vieira
President, Oncology
Yuan Xu
Senior Manager, Statistical Programming
Recent News
TradingView
2024-11-06
2024-10-31
2024-05-28
Company data provided by crunchbase
